TERRAFORMATION
21.9.2022 15:09:38 CEST | Business Wire | Press release
Terraformation, the world’s first global forest carbon accelerator, today announces the launch of the Seed to Forest Alliance, with American Forests, Ecosystem Restoration Camps and One Tree Planted as founding members, as well as 1t.org US as an advisory partner.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220915005905/en/
Estimated Number of seed banks still needed per country based on low, medium and high “need for seeds scenarios". Source: Terraformation
Launching at Climate Week NYC 2022, the Alliance supports biodiverse, native reforestation by providing a network to connect forestry teams with financial and technical support; members, who will include corporates, NGOs, and philanthropists, will contribute to research and thought leadership to accelerate reforestation, and share results, best practices and expertise to help the reforestation movement overcome the largest bottlenecks to scale.
The Alliance will initially focus on inadequate seed supply as a barrier to reforestation at scale. New research published today by Terraformation sheds light on the significant scale of upgrades required in the world’s existing seed banking infrastructure to meet global restoration goals.
In recent years, global companies have committed to planting over 3.6 billion trees in their sustainability plans. At COP26, $7.2 billion of private investment was committed to protect and restore forests. However, these targets are not achievable without investment and innovation in global seed banking infrastructure.
Yishan Wong, founder and CEO of Terraformation, said: “Lasting climate solutions only come from collective action across diverse stakeholders. We’re incredibly excited to be working with organizations with the expertise, influence and determination to have a real impact on reforestation around the world. Native ecosystem restoration — with the right plants in the right places — is the most effective and immediately scalable carbon capture solution. Together, we can restore the future of our planet by conserving one of our most valuable resources at the heart of restoration: the seeds.”
Kevin O’Hara, Lead of 1t.org US at American Forests, added: “Time and time again we hear the real and immediate challenges in finding the seeds necessary to reach our ambitious national reforestation goals. 1t.org US is proud to support the work the Seed to Forest Alliance will do to help lift up public, private and NGO efforts to ramp up seed supply here in the US and around the world.”
New research reveals urgency for global seed bank network
Against this backdrop, Terraformation has published The Global Seed Bank Index, the first global review of seed banking infrastructure. The report analyzed the number of seed banks needed to meet the “global restoration potential,” defined as the area of land in the world available for ecological restoration.
The research found that a global decentralized seed bank network would drastically improve restoration outcomes, preserve threatened species, and benefit local communities.
Key findings include:
- Currently, 410 seed banks store native species for ecosystem restoration across 96 countries, but more are needed in almost all countries. Establishing larger regional seed banks could help meet the need for seeds more efficiently.
- More than half of the world’s countries have no known seed banks.
- While the United States, Australia, Brazil and China have the most seed banks, they also need the most new seed banks to meet their restoration potential within 10 years.
- The restoration movement will also need to train hundreds of thousands of new seed collectors to preserve and restore threatened biodiversity.
- The tropics and biodiversity hotspots are the highest priority locations for additional seed banking capacity given their high impact on biodiversity and climate regulation.
Following the study, Terraformation is calling on:
- Businesses to invest in seed banks in their sustainability plans: seed banks are a tangible restoration solution that directly support the UN’s Sustainable Development Goals.
- Governments to support seed banks as a natural resource management strategy: government support at any level can help create a well-connected and scalable decentralized network with locally adapted, resilient seeds.
- Local restoration organizations to prioritize seed banking: people already doing restoration on the ground can add seed banking to their restoration toolkits and scale their work with higher efficiency.
Seed to Forest Alliance
Terraformation and its Alliance members are committed to scaling solutions to the largest bottlenecks to native forest restoration. Four of the largest bottlenecks are inadequate seed supplies, a lack of on-the-ground technical expertise, data accessibility, and insufficient financing. The Alliance will first focus on seed supply, connecting forestry groups with the funding, technology and training to establish local seed supplies and enable biodiverse reforestation at scale.
The Alliance is underpinned by three guiding principles:
- Biodiversity and ecological resilience: the Alliance will only support native, biodiverse forest restoration in accordance with the IUCN Global Standard for Nature-based Solutions. It does not support monocultures or destructive forestry practices.
- Community: the Alliance believes communities are at the heart of resilient and just land restoration. It supports forest restoration projects in alignment with UN Sustainable Development Goals, especially with regard to gender equality, decent work, human health and well-being, and elimination of poverty.
- Measurable impact and transparency: the Alliance prioritizes impact, and as such will set quantifiable goals and transparently report progress.
The Global Seed Bank Index is available to download here.
- ENDS -
About Terraformation
Terraformation is dedicated to restoring the world's forests to stabilize our climate, revive ecosystems, and build thriving communities.
It is launching a forest carbon accelerator, supporting early-stage forestry teams to launch, build, and scale biodiverse reforestation projects and produce high-quality, verified carbon credits.
Terraformation’s partner network spans five continents and includes diverse landowners and organizations. It was founded in 2019 by Yishan Wong, former CEO of Reddit.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005905/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 07:30:00 CET | Press release
Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob
Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 06:30:00 CET | Press release
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan
VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 01:00:00 CET | Press release
Enabling Next-Generation High-Performance Automotive Camera Systems VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise
Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 22:30:00 CET | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 22:30:00 CET | Press release
Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
